| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |